• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_SMART TOUCH UNIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_SMART TOUCH UNIDIRECTIONAL SF; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Catalog Number UNK_SMART TOUCH UNIDIRECTIONAL
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Transient Ischemic Attack (2109); Cardiac Tamponade (2226)
Event Date 08/26/2021
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).This complaint is from a literature source.The following literature cite has been reviewed: tahin t, riba a, nemeth b, arvai f, lupkovics g, szeplaki g, geller l.Implementation of a zero fluoroscopic workflow using a simplified intracardiac echocardiography guided method for catheter ablation of atrial fibrillation, including repeat procedures.Bmc cardiovasc disord.2021 aug 26;21(1):407.Doi: 10.1186/s12872-021-02219-8.Pmid: 34433424; pmcid: pmc8390247.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was not provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: tahin t, riba a, nemeth b, arvai f, lupkovics g, szeplaki g, geller l.Implementation of a zero fluoroscopic workflow using a simplified intracardiac echocardiography guided method for catheter ablation of atrial fibrillation, including repeat procedures.Bmc cardiovasc disord.2021 aug 26;21(1):407.Doi: 10.1186/s12872-021-02219-8.Pmid: 34433424; pmcid: pmc8390247.Objective/methods/study data: aim was to describe our experience in the implementation of an intracardiac echocardiography (ice) guided zero fluoroscopic (zf) ablation approach to our routine clinical practice.Simplified ice guided technique to perform ablation procedures for af, with the aid of a 3d electro anatomical mapping system.The workflow was implemented in two phases: the introductory phase, where the first 16 zf pvis were compared with 16 cases performed with fluoroscopy and the extension phase, where 71 consecutive patients (including repeat procedures) with zf approach were included.Standard pvi (and redo pvi) procedures were performed, data on feasibility of the zf approach, complications, acute and 1-year success rates were collected.Te study consisted of two main phases: the introductory phase, where the aim was to test the safety and feasibility of the zero-fluoroscopy (zf) technique versus the conventionally used, fluoroscopy guided (fl) workflow and the extension phase, where the longer-term outcomes were tested using the zf strategy in consecutive patients.A total of 103 patients were enrolled into the study between january 2017 and december 2018, who underwent catheter ablation by pulmonary vein isolation (pvi) for symptomatic, non-valvular atrial fibrillation at the centre.For the fl group the puncture was guided by fluoroscopy and ice.Both groups utilized biosense devices for mapping and ablation.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: an irrigated contact force sensing ablation catheter (thermocool smarttouch¿ 8fr).Other biosense webster devices that were also used in this study: 20-pole lasso catheter, carto3¿ electro anatomical mapping system, a 10f ice catheter in the fl group only (accuson accunav).Non-biosense webster devices that were also used in this study: a decapolar reference catheter (dynamic deca, boston scientific).Adverse event(s) and provided interventions: qty 2 tamponades (both treated with pericardiocentesis and both discharged without additional treatment).Qty 1 tia noted after recovery from procedure but resolved by the following day without any residual symptoms (treatment not listed).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_SMART TOUCH UNIDIRECTIONAL SF
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12592597
MDR Text Key277994389
Report Number2029046-2021-01699
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeHU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_SMART TOUCH UNIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-